search
Back to results

Exercise Training to Promote Resilience to Chronic Lymphocytic Leukemia (HIIT-CLL)

Primary Purpose

Aging, Chronic Lymphocytic Leukemia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise Training
Sponsored by
Duke University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Aging

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Confirmed diagnosis of CLL as per the International Workshop on CLL Guidelines.
  • Male or female ≥ 18 years of age
  • No history of prior treatment of CLL
  • Able to walk on a treadmill or cycle on an ergometer
  • Pass the CPET evaluation of aerobic fitness and cardiac health

Exclusion Criteria:

  • Clinical evidence of significant disease progression with first line therapy expected within 6 months
  • Corticosteroid therapy initiated less than 7 days prior to study entry. Prednisone 10mg or less or equivalent is allowed as clinically warranted. Topical or inhaled corticosteroids are permitted.
  • Malignancy within 3 years of study enrollment requiring intervention except for adequately treated basal, squamous cell carcinoma or non-melanomatous skin cancer, carcinoma in situ of the cervix, superficial bladder cancer not treated with intravesical chemotherapy or BCG within 6 months, localized prostate cancer and PSA stable
  • Absolute contra-indications to exercise: Recent (<6 months) acute cardiac event unstable angina, uncontrolled dysrhythmias causing symptoms or hemodynamic compromise, symptomatic aortic stenosis, uncontrolled symptomatic heart failure, acute pulmonary embolus, acute myocarditis or pericarditis, suspected or known dissecting aneurism and acute systemic infection.
  • Significant orthopedic limitations, musculoskeletal disease and/or injury. Due to the nature of the study, persons with known joint, muscle or other orthopedic limitations that restrict physical activity may be excluded.
  • Type I diabetes mellitus or uncontrolled Type II diabetes mellitus (HbA1c >7%), or chronic obstructive pulmonary disease
  • Uncontrolled blood pressure (≥180/90) at rest during screening and confirmed on repeat manual measurement
  • Unable to travel to fitness center or comply with other study requirements
  • Known concurrent HIV, Hepatitis B or Hepatitis C

Sites / Locations

  • Duke University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

CLL-EX

CLL-CON

Arm Description

Subjects will undergo supervised exercise training 3 x per week for 12 weeks. Three/sessions per week will consist of intervals of high-intensity (~85% of maximal capacity) will be 5 to 10 bouts of 30 seconds at this intensity with rest periods in between intervals that range from 30 seconds to 2 minutes. Following this, on 2 occasions/week subjects will complete muscular endurance resistance training on machine weights.

Subjects will not receive supervised exercise training and will be asked to maintain their daily lifestyle behaviors.

Outcomes

Primary Outcome Measures

Change in VO2peak as measured by cardiopulmonary exercise test

Secondary Outcome Measures

Change in lymphocyte doubling rate (LDR) as measured by blood test
Change in muscle strength as measured by a strength test
Strength test is the estimated maximal amount of weight a subject can lift
Change in muscle endurance as measured by a muscle endurance test
Endurance test is the amount of times a subject can lift 70% of maximal muscle strength
Change in neutrophil to lymphocyte ratio (NLR) as measured by blood test
Change in lymphocyte to monocyte ratio (LMR) as measured by blood test
Change in natural killer cell killing of tumor cell lines as measured by flow cytometry
Change in neutrophil killing of E.coli as measured by flow cytometry

Full Information

First Posted
June 23, 2021
Last Updated
June 29, 2021
Sponsor
Duke University
search

1. Study Identification

Unique Protocol Identification Number
NCT04950452
Brief Title
Exercise Training to Promote Resilience to Chronic Lymphocytic Leukemia
Acronym
HIIT-CLL
Official Title
Exercise Training to Promote Resilience to Chronic Lymphocytic Leukemia in Older Adults by Enhancing Physical and Immunological Reserve
Study Type
Interventional

2. Study Status

Record Verification Date
June 2021
Overall Recruitment Status
Completed
Study Start Date
August 22, 2018 (Actual)
Primary Completion Date
January 6, 2020 (Actual)
Study Completion Date
January 6, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Duke University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
PURPOSE: The purpose of the study is to determine the effects of 12-weeks of exercise training on physical reserve, as measured by aerobic capacity, strength and physical function, in patients with CLL. Further, it is our aim to assess relationships with changes in physical reserve and resilience to the patient's cancer, as measured by immune cell counts, tumor cell killing and antibacterial functions. DESIGN: Subjects will have confirmed treatment naïve CLL. Subjects will be assigned to either a 12-week control (no supervised exercise) or an intervention (HIIT) group. Before and after the 12 week program subjects will undergo several tests including: 1) a maximal treadmill test, 2) body composition, 3) muscle strength and endurance, 4) physical activity levels, 5) blood measures (e.g. immune and inflammatory functions). Subjects in the HIIT group will complete a 12-week supervised exercise training program consisting of HIIT and strength training. DATA ANALYSES & SAFETY ISSUES: This is a pilot study, with the goal of assessing whether exercise training causes a change in aerobic fitness (VO2peak), muscle function, and immunological measures. Vo2peak will be measured by a cardiopulmonary exercise test, muscle function will be measured by strength tests, and immunological functions will be measured from blood samples. For outcomes, group change differences from baseline to 12-weeks will be compared by ANCOVA. The data will be used to provide power calculations for future grant proposals. High Intensity Interval Training is a very safe exercise modality. The regular use of vigorous intensity exercise intervals have been used extensively in exercise training. In fact, the exercise intervals will start at levels lower and will be of shorter duration than were used during the maximal exercise test. They will then be carefully and slowly made to be more challenging as each subject is able to safely tolerate. HYPOTHESIS: The investigators hypothesize that HIIT will be a feasible exercise intervention for people with CLL and will result in improvements in markers of health and fitness.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aging, Chronic Lymphocytic Leukemia

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CLL-EX
Arm Type
Experimental
Arm Description
Subjects will undergo supervised exercise training 3 x per week for 12 weeks. Three/sessions per week will consist of intervals of high-intensity (~85% of maximal capacity) will be 5 to 10 bouts of 30 seconds at this intensity with rest periods in between intervals that range from 30 seconds to 2 minutes. Following this, on 2 occasions/week subjects will complete muscular endurance resistance training on machine weights.
Arm Title
CLL-CON
Arm Type
No Intervention
Arm Description
Subjects will not receive supervised exercise training and will be asked to maintain their daily lifestyle behaviors.
Intervention Type
Behavioral
Intervention Name(s)
Exercise Training
Intervention Description
Supervised exercise training
Primary Outcome Measure Information:
Title
Change in VO2peak as measured by cardiopulmonary exercise test
Time Frame
Baseline to 12-weeks
Secondary Outcome Measure Information:
Title
Change in lymphocyte doubling rate (LDR) as measured by blood test
Time Frame
Baseline to 12-weeks
Title
Change in muscle strength as measured by a strength test
Description
Strength test is the estimated maximal amount of weight a subject can lift
Time Frame
Baseline to 12-weeks
Title
Change in muscle endurance as measured by a muscle endurance test
Description
Endurance test is the amount of times a subject can lift 70% of maximal muscle strength
Time Frame
Baseline to 12-weeks
Title
Change in neutrophil to lymphocyte ratio (NLR) as measured by blood test
Time Frame
Baseline to 12-weeks
Title
Change in lymphocyte to monocyte ratio (LMR) as measured by blood test
Time Frame
Baseline to 12-weeks
Title
Change in natural killer cell killing of tumor cell lines as measured by flow cytometry
Time Frame
Baseline to 12-weeks
Title
Change in neutrophil killing of E.coli as measured by flow cytometry
Time Frame
Baseline to 12-weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Confirmed diagnosis of CLL as per the International Workshop on CLL Guidelines. Male or female ≥ 18 years of age No history of prior treatment of CLL Able to walk on a treadmill or cycle on an ergometer Pass the CPET evaluation of aerobic fitness and cardiac health Exclusion Criteria: Clinical evidence of significant disease progression with first line therapy expected within 6 months Corticosteroid therapy initiated less than 7 days prior to study entry. Prednisone 10mg or less or equivalent is allowed as clinically warranted. Topical or inhaled corticosteroids are permitted. Malignancy within 3 years of study enrollment requiring intervention except for adequately treated basal, squamous cell carcinoma or non-melanomatous skin cancer, carcinoma in situ of the cervix, superficial bladder cancer not treated with intravesical chemotherapy or BCG within 6 months, localized prostate cancer and PSA stable Absolute contra-indications to exercise: Recent (<6 months) acute cardiac event unstable angina, uncontrolled dysrhythmias causing symptoms or hemodynamic compromise, symptomatic aortic stenosis, uncontrolled symptomatic heart failure, acute pulmonary embolus, acute myocarditis or pericarditis, suspected or known dissecting aneurism and acute systemic infection. Significant orthopedic limitations, musculoskeletal disease and/or injury. Due to the nature of the study, persons with known joint, muscle or other orthopedic limitations that restrict physical activity may be excluded. Type I diabetes mellitus or uncontrolled Type II diabetes mellitus (HbA1c >7%), or chronic obstructive pulmonary disease Uncontrolled blood pressure (≥180/90) at rest during screening and confirmed on repeat manual measurement Unable to travel to fitness center or comply with other study requirements Known concurrent HIV, Hepatitis B or Hepatitis C
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David Bartlett, PhD
Organizational Affiliation
Duke University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Andrea Sitlinger, MD
Organizational Affiliation
Duke University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Duke University
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27705
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
36096873
Citation
Artese AL, Sitlinger A, MacDonald G, Deal MA, Hanson ED, Pieper CF, Weinberg JB, Brander DM, Bartlett DB. Effects of high-intensity interval training on health-related quality of life in chronic lymphocytic leukemia: A pilot study. J Geriatr Oncol. 2023 Jan;14(1):101373. doi: 10.1016/j.jgo.2022.09.002. Epub 2022 Sep 9.
Results Reference
derived
PubMed Identifier
34848750
Citation
MacDonald G, Sitlinger A, Deal MA, Hanson ED, Ferraro S, Pieper CF, Weinberg JB, Brander DM, Bartlett DB. A pilot study of high-intensity interval training in older adults with treatment naive chronic lymphocytic leukemia. Sci Rep. 2021 Nov 30;11(1):23137. doi: 10.1038/s41598-021-02352-6.
Results Reference
derived

Learn more about this trial

Exercise Training to Promote Resilience to Chronic Lymphocytic Leukemia

We'll reach out to this number within 24 hrs